Concepedia

Jayakumar R. Nair

JR

28

Publications

1.7K

Citations

20

H-Index

1988

Active since

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

National Cancer Institute

Center for Cancer Research

National Institutes of Health

Emory University

Jayakumar R. Nair is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

1988–2024

28

Publications

28

Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study

Jung‐Min Lee, Jayakumar R. Nair, Alexandra S. Zimmer et al. · The Lancet Oncology · 2018 · 210 citations · Full text

, , +6

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Erika J. Lampert, Alexandra S. Zimmer, Michelle R. Padget et al. · Clinical Cancer Research · 2020 · 209 citations · Full text

Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells

Henryk Różański, Ramon Arens, Louise Carlson et al. · The Journal of Experimental Medicine · 2011 · 174 citations · Full text

KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

Sudha Mannava, Dazhong Zhuang, Jayakumar R. Nair et al. · Blood · 2011 · 88 citations · Full text

CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma

Megan Murray, Catherine M. Gavile, Jayakumar R. Nair et al. · Blood · 2014 · 88 citations · Full text

Rows per page

1–5 of 28